Daily non-political popular news in brief.

How does Fu-Zheng-Jie-Du-Decoction act on PTEN expression in hepatocellular carcinoma?

01-16-2008 · EurekAlert!

Hepatocellular carcinoma is one of the major cancer killers. Traditional Chinese Medicine has been widely used as a combined therapy in treating the disease in China. How TCM works is still unknown. A research group in China has found TCM can down-regulate the expression of PTEN (Phosphatase and Tensin Homolog deleted on Chromosome 10) in HCC which may suppress tumor cell growth and regulate tumor cell invasion and metastasis.

Keywords: fu-zheng-jie-du-decoction, act, pten, expression, hepatocellular, carcinoma, zheng, jie, decoction

« Previous | Next »

Similar news on "How does Fu-Zheng-Jie-Du-Decoction act on PTEN expression in hepatocellular carcinoma?":

Massive necrosis after trans-catheter treatment is more common in the presence of tumor capsule
11-24-2007 · EurekAlert!
In a study led by Dr. Roberto Miraglia from the Mediterranean Institute for Transplantation and Advanced Specialized Therapies, predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma were evaluated. A multivariate analysis of pre-treatment findings in 200 patients found that massive necrosis after trans-catheter treatment is more common in the presence of tumor capsule, with the maximum diameter of the main lesion between 2-66 cm, CLIP score < 2 and the absence of constitutional syndrome.
Similar news · Read more »
Gene variation may elevate risk of liver tumor in patients with cirrhosis
01-01-2008 · EurekAlert!
A particular gene variation appears to significantly increase the risk that individuals with cirrhosis of the liver will go on to develop hepatocellular carcinoma, a liver tumor that is the third leading cause of cancer death. Researchers from Massachusetts General Hospital Cancer Center and colleagues in France have found that a single alteration in the epidermal growth factor gene may greatly increase the risk that cirrhotic patients will develop the tumor.
Similar news · Read more »
Coffee drinking related to reduced risk of liver cancer
08-01-2007 · EurekAlert!
A new study on the relationship between coffee drinking and the risk of hepatocellular carcinoma confirmed that there is an inverse association between coffee consumption and HCC, although the reasons for this relationship are still unresolved.
Similar news · Read more »
Targeting nerve growth factor may cure liver cancer
09-05-2007 · EurekAlert!
Biologists led by Dr. Serafino from the National Research Council of Italy published their surprising discovery that NGF and its receptor were aberrantly expressed in the liver of the patients troubled with liver cirrhosis and/or hepatocellular carcinoma (HCC). These two molecules are not expressed in the liver of healthy people. Published in the October 7 issue of the World Journal of gastroenterology, this article brings a bright future for devising a cure for HCC.
Similar news · Read more »
Nexavar shown to significantly extend survival for patients with advanced liver cancer
02-12-2007 · EurekAlert!
Bayer Pharmaceuticals Corp., and Onyx Pharmaceuticals, Inc., today announced that an independent data monitoring committee (DMC) has reviewed the safety and efficacy data from the companies' pivotal Phase 3 trial in patients with advanced hepatocellular carcinoma (HCC), or primary liver cancer.
Similar news · Read more »
Targeting nerve growth factor may cure liver cancer
09-19-2007 · EurekAlert!
Biologists led by Dr. Serafino from the National Research Council of Italy published their surprising discovery that NGF and its receptor were aberrantly expressed in the liver of the patients troubled with liver cirrhosis and/or hepatocellular carcinoma. These two molecules are not expressed in the liver of healthy people. Published in the Oct. 7 issue of the World Journal of gastroenterology, this article brings a bright future for devising a cure for HCC.
Similar news · Read more »
Outcomes for patients with hepatitis B who need liver transplants
03-02-2007 · EurekAlert!
Survival rates are similar among patients with hepatitis B who are listed for liver transplantation, whether or not they have hepatocellular carcinoma (HCC), according to a new study in the March 2007 issue of Liver Transplantation. An accompanying editorial suggests that these results affirm the current policy on the allocation of donor livers.
Similar news · Read more »
A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
10-13-2007 · EurekAlert!
Human hepatocellular carcinoma is a challenging disease worldwide and researchers have long sought an effective cure. A research group in China has found that a Chinese medicinal compound, delisheng, had satisfactory anti-cancer effects on HCC with one exceptive, cell culture model and these were associated with the up-regulation of endostatin.
Similar news · Read more »
Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
10-17-2007 · EurekAlert!
The prognosis of patients with hepatocellular carcinoma accompanied by portal vein tumor thrombus is generally poor. Ten such patients treated by intra-arterial infusion of etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and tegafur/uracil are survival for 457.2 days, an one year survival rate was 70 percent. This combination chemotherapy may induce long-term survival and is an effective treatment in patients for HCC with PVTT.
Similar news · Read more »
A new chemotherapeutic target for hepatocellular carcinoma
10-25-2007 · EurekAlert!
Many of hepatocellular carcinomas with scattered tumors cannot be operated on and therefore, in such patients, transcatheter arterial chemoembolization is performed as an important alternative treatment. This study suggests that survivin inhibition for early HCC could be potentially useful as an effective interventional radiological treatment modality.
Similar news · Read more »